drugset / Trial / NCT02173691

Efficacy and Safety of Tiotropium Compared to Salmeterol and Placebo in Patients With Chronic Obstructive Bronchitis (COPD)

NCT02173691

Phase 3 Completed 584 enrolled Boehringer Ingelheim
RandomizedParallel-groupDouble-blindTreatment

Summary

The objective of this study is to compare the long-term (six month) bronchodilator efficacy and safety of tiotropium inhalation capsules, salmeterol inhalation aerosol and placebo inpatients with COPD.

Timeline

Start
1999-02
Primary completion
2000-05
Completion

Drugs

EvaluationDrugModalityDoseRoute
Comparator Salmeterol Other / unclassified Other
Subject Tiotropium Other / unclassified Other